Condition: Lung Diseases · Sponsor: Johns Hopkins University
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.
This description comes directly from the study's public registry record.
Elizabeth Sugar, PhD · 443-287-3170 · esugar2@jhu.edu
Curt Reynolds, MAS · 410-614-2422 · creynol1@jhu.edu
Always discuss trial participation with your own doctor first.
| University Of Alabama | Birmingham, Alabama, United States | Recruiting |
| University of Arizona-Tuscon | Tucson, Arizona, United States | Recruiting |
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| University of Colorado | Aurora, Colorado, United States | Active Not Recruiting |
| National Jewish Health | Denver, Colorado, United States | Recruiting |
| Nemours Children's Jacksonville | Jacksonville, Florida, United States | Recruiting |
| University of Florida, Jacksonville | Jacksonville, Florida, United States | Recruiting |
| University of Illinois at Chicago | Chicago, Illinois, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Rush Universtiy | Chicago, Illinois, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Withdrawn |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04543461